Efficacy of Natalizumab in a French Cohort of Multiple Sclerosis Patients

被引：0
|
作者：
Outteryck, Olivier
Ongagna, Jean-Claude
Zephir, Helene
Fleury, M. -C.
Lacour, Arnaud
Blanc, Frederic
Vermersch, Patrick
de Seze, Jerome
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A550 / A551
页数：2
相关论文
共 50 条
  • [1] Natalizumab: A study of efficacy and safety in a multiple sclerosis Brazilian cohort
    Deslandes, Mariana Quintanilha
    Ferreira Vasconcelos, Claudia Cristina
    Alvarenga, Marcos Papais
    Alves, Pedro Thiago
    Nobrega, Felipe Resende
    Das Gracas Gomes Camargo, Solange Maria
    Batista, Elisabeth
    Colares, Vanessa
    Papais Alvarenga, Regina Maria
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 171 - 172
  • [2] Efficacy of Natalizumab in African American Multiple Sclerosis Patients
    Perumal, Jai S.
    Laing, Lisa S.
    Gazivoda, Kristina S.
    Babinski, Kristen
    Howard, Jonathan
    Kister, Ilya
    Herbert, Joseph
    NEUROLOGY, 2011, 76 (09) : A474 - A474
  • [3] TYSEDMUS: National cohort of multiple sclerosis patients treated with natalizumab using the French EDMUS (European Database for Multiple Sclerosis) network
    Vukusic, Sandra
    Passante, Nadine
    Zanetti, Laura
    Ritleng, Cecile
    Laforest, Laurent
    Van Ganse, Eric
    Rocher, Fanny
    Clanet, Michel
    Castot, Anne
    Confavreux, Christian
    MULTIPLE SCLEROSIS, 2008, 14 : S184 - S184
  • [4] EVALUATING THE INTRODUCTION OF SUBCUTANEOUS NATALIZUMAB TO A COHORT OF PATIENTS WITH MULTIPLE SCLEROSIS
    Edwards, Marc
    Pearson, Owen
    Ingram, Gillian
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [5] Efficacy and safety of Natalizumab treatment for relapsing-remitting multiple sclerosis: results from a retrospective French cohort
    Beyrouti, R.
    Courtois, S.
    Penombre, E.
    Mostoufizadeh, S.
    Cohen, E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 649 - 649
  • [6] Multiple Sclerosis Natalizumab: Efficacy with risk
    Diener, H. C.
    Hecht, Birgit
    PSYCHOPHARMAKOTHERAPIE, 2010, 17 (02): : 106 - 108
  • [7] Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
    Hoepner, Robert
    Faissner, Simon
    Salmen, Anke
    Gold, Ralf
    Chan, Andrew
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2014, 6 : 41 - 49
  • [8] Effect of Natalizumab on Clinical and Radiological Disease Activity in a French Cohort of Relapsing Remitting Multiple Sclerosis Patients
    Melin, Annick
    Outteryck, Olivier
    Ongagna, Jean-Claude
    Fleury, Marie
    Zephir, Helene
    Lacour, Arnaud
    Berteloot, Anne-Sophie
    Blanc, Frederic
    Vermersch, Patrick
    De Seze, Jerome
    NEUROLOGY, 2011, 76 (09) : A71 - A71
  • [9] Long-term effect of natalizumab in a French cohort of patients with relapsing-remitting multiple sclerosis: TYSTEN cohort
    Bigaut, Kevin
    Fabacher, Thibaut
    Collongues, Nicolas
    Kremer, Laurent
    Fleury, Marie-Celine
    Ongagna, Jean-Claude
    De Seze, Jerome
    NEUROLOGY, 2018, 90
  • [10] Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program
    van Pesch, Vincent
    Bartholome, Emmanuel
    Bissay, Veronique
    Bouquiaux, Olivier
    Bureau, Michel
    Caekebeke, Jo
    Debruyne, Jan
    Declercq, Inge
    Decoo, Dany
    Denayer, Pierre
    De Smet, Eric
    D'hooghe, Marie
    Dubois, Benedicte
    Dupuis, Michel
    El Sankari, Souraya
    Geens, Karine
    Guillaume, Daniel
    van Landegem, William
    Lysandropoulos, Andreas
    de Noordhout, Alain Maertens
    Medaer, Robert
    Melin, Annick
    Peeters, Katelijne
    Remy Phan Ba
    Retif, Cecile
    Seeldrayers, Pierrette
    Symons, Anoek
    Urbain, Etienne
    Vanderdonckt, Patrick
    Van Ingelghem, Erwin
    Vanopdenbosch, Ludo
    Vanroose, Erwin
    Van Wijmeersch, Bart
    Willekens, Barbara
    Willems, Christiana
    Sindic, Christian
    ACTA NEUROLOGICA BELGICA, 2014, 114 (03) : 167 - 178
12345